Immunotherapeutics against cancer and infectious diseases

ISA Pharmaceuticals B.V. is developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections.

News

September 21, 2016
ISA Pharmaceuticals' CSO Prof. Cornelis Melief to Present at CRI-CIMT-EATI-AACR Meeting in New York City
July 1, 2016
ISA Pharmaceuticals´ CSO Kees Melief researcher of the week of the Dutch Cancer Society (DCS)

Events

September 25 – 28, 2016
CRI-CIMT-EATI-AACR
October 7 – 11, 2016
European Society for Medical Oncology (ESMO)

Latest Publications

September 5, 2016
Cancer Research / Science Translational Medicine
Cancer Research / Science Translational Medicine

More news

More events

More publications

Loading Quotes...